1016 related articles for article (PubMed ID: 27122584)
1. Biphasic CD8+ T-Cell Defense in Simian Immunodeficiency Virus Control by Acute-Phase Passive Neutralizing Antibody Immunization.
Iseda S; Takahashi N; Poplimont H; Nomura T; Seki S; Nakane T; Nakamura M; Shi S; Ishii H; Furukawa S; Harada S; Naruse TK; Kimura A; Matano T; Yamamoto H
J Virol; 2016 Jul; 90(14):6276-6290. PubMed ID: 27122584
[TBL] [Abstract][Full Text] [Related]
2. Post-infection immunodeficiency virus control by neutralizing antibodies.
Yamamoto H; Kawada M; Takeda A; Igarashi H; Matano T
PLoS One; 2007 Jun; 2(6):e540. PubMed ID: 17579714
[TBL] [Abstract][Full Text] [Related]
3. Limited impact of passive non-neutralizing antibody immunization in acute SIV infection on viremia control in rhesus macaques.
Nakane T; Nomura T; Shi S; Nakamura M; Naruse TK; Kimura A; Matano T; Yamamoto H
PLoS One; 2013; 8(9):e73453. PubMed ID: 24039947
[TBL] [Abstract][Full Text] [Related]
4. [In vivo protective mechanisms of neutralizing antibodies against simian immunodeficiency virus replicatio].
Yamamoto H
Uirusu; 2021; 71(1):87-96. PubMed ID: 35526999
[TBL] [Abstract][Full Text] [Related]
5. Late-phase dominance of a single epitope-specific CD8+ T-cell response in passive neutralizing antibody-infused simian immunodeficiency virus controllers.
Kanno Y; Hau TTT; Kurokawa R; Nomura T; Nishizawa M; Matano T; Yamamoto H
AIDS; 2021 Nov; 35(14):2281-2288. PubMed ID: 34224443
[TBL] [Abstract][Full Text] [Related]
6. Long-term control of simian immunodeficiency virus replication with central memory CD4+ T-cell preservation after nonsterile protection by a cytotoxic T-lymphocyte-based vaccine.
Kawada M; Tsukamoto T; Yamamoto H; Takeda A; Igarashi H; Watkins DI; Matano T
J Virol; 2007 May; 81(10):5202-11. PubMed ID: 17344296
[TBL] [Abstract][Full Text] [Related]
7.
Martins MA; Tully DC; Pedreño-Lopez N; von Bredow B; Pauthner MG; Shin YC; Yuan M; Lima NS; Bean DJ; Gonzalez-Nieto L; Domingues A; Gutman MJ; Maxwell HS; Magnani DM; Ricciardi MJ; Bailey VK; Altman JD; Burton DR; Ejima K; Allison DB; Evans DT; Rakasz EG; Parks CL; Bonaldo MC; Capuano S; Lifson JD; Desrosiers RC; Allen TM; Watkins DI
J Virol; 2018 Aug; 92(16):. PubMed ID: 29875239
[TBL] [Abstract][Full Text] [Related]
8. Rectal Acquisition of Simian Immunodeficiency Virus (SIV) SIVmac239 Infection despite Vaccine-Induced Immune Responses against the Entire SIV Proteome.
Martins MA; Gonzalez-Nieto L; Ricciardi MJ; Bailey VK; Dang CM; Bischof GF; Pedreño-Lopez N; Pauthner MG; Burton DR; Parks CL; Earl P; Moss B; Rakasz EG; Lifson JD; Desrosiers RC; Watkins DI
J Virol; 2020 Nov; 94(24):. PubMed ID: 33028714
[TBL] [Abstract][Full Text] [Related]
9. Neutralizing antibodies in SIV control: co-impact with T cells.
Yamamoto H; Matano T
Vaccine; 2010 May; 28 Suppl 2():B13-7. PubMed ID: 20510737
[TBL] [Abstract][Full Text] [Related]
10. Emergence of simian immunodeficiency virus-specific cytotoxic CD4+ T cells and increased humoral responses correlate with control of rebounding viremia in CD8-depleted macaques infected with Rev-independent live-attenuated simian immunodeficiency virus.
von Gegerfelt A; Valentin A; Alicea C; Van Rompay KK; Marthas ML; Montefiori DC; Pavlakis GN; Felber BK
J Immunol; 2010 Sep; 185(6):3348-58. PubMed ID: 20702730
[TBL] [Abstract][Full Text] [Related]
11. Linking pig-tailed macaque major histocompatibility complex class I haplotypes and cytotoxic T lymphocyte escape mutations in simian immunodeficiency virus infection.
Gooneratne SL; Alinejad-Rokny H; Ebrahimi D; Bohn PS; Wiseman RW; O'Connor DH; Davenport MP; Kent SJ
J Virol; 2014 Dec; 88(24):14310-25. PubMed ID: 25275134
[TBL] [Abstract][Full Text] [Related]
12. Involvement of multiple epitope-specific cytotoxic T-lymphocyte responses in vaccine-based control of simian immunodeficiency virus replication in rhesus macaques.
Kawada M; Igarashi H; Takeda A; Tsukamoto T; Yamamoto H; Dohki S; Takiguchi M; Matano T
J Virol; 2006 Feb; 80(4):1949-58. PubMed ID: 16439550
[TBL] [Abstract][Full Text] [Related]
13. Polyfunctional CD4+ T-cell induction in neutralizing antibody-triggered control of simian immunodeficiency virus infection.
Yamamoto T; Iwamoto N; Yamamoto H; Tsukamoto T; Kuwano T; Takeda A; Kawada M; Tsunetsugu-Yokota Y; Matano T
J Virol; 2009 Jun; 83(11):5514-24. PubMed ID: 19297503
[TBL] [Abstract][Full Text] [Related]
14. Containment of simian immunodeficiency virus infection in vaccinated macaques: correlation with the magnitude of virus-specific pre- and postchallenge CD4+ and CD8+ T cell responses.
Hel Z; Nacsa J; Tryniszewska E; Tsai WP; Parks RW; Montefiori DC; Felber BK; Tartaglia J; Pavlakis GN; Franchini G
J Immunol; 2002 Nov; 169(9):4778-87. PubMed ID: 12391187
[TBL] [Abstract][Full Text] [Related]
15. The Frequency of Vaccine-Induced T-Cell Responses Does Not Predict the Rate of Acquisition after Repeated Intrarectal SIVmac239 Challenges in
Martins MA; Gonzalez-Nieto L; Shin YC; Domingues A; Gutman MJ; Maxwell HS; Magnani DM; Ricciardi MJ; Pedreño-Lopez N; Bailey VK; Altman JD; Parks CL; Allison DB; Ejima K; Rakasz EG; Capuano S; Desrosiers RC; Lifson JD; Watkins DI
J Virol; 2019 Mar; 93(5):. PubMed ID: 30541854
[TBL] [Abstract][Full Text] [Related]
16. Differential Impact of In Vivo CD8+ T Lymphocyte Depletion in Controller versus Progressor Simian Immunodeficiency Virus-Infected Macaques.
Chowdhury A; Hayes TL; Bosinger SE; Lawson BO; Vanderford T; Schmitz JE; Paiardini M; Betts M; Chahroudi A; Estes JD; Silvestri G
J Virol; 2015 Sep; 89(17):8677-86. PubMed ID: 26063417
[TBL] [Abstract][Full Text] [Related]
17. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes.
Schmitz JE; Kuroda MJ; Santra S; Sasseville VG; Simon MA; Lifton MA; Racz P; Tenner-Racz K; Dalesandro M; Scallon BJ; Ghrayeb J; Forman MA; Montefiori DC; Rieber EP; Letvin NL; Reimann KA
Science; 1999 Feb; 283(5403):857-60. PubMed ID: 9933172
[TBL] [Abstract][Full Text] [Related]
18. Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes.
Barouch DH; Kunstman J; Kuroda MJ; Schmitz JE; Santra S; Peyerl FW; Krivulka GR; Beaudry K; Lifton MA; Gorgone DA; Montefiori DC; Lewis MG; Wolinsky SM; Letvin NL
Nature; 2002 Jan; 415(6869):335-9. PubMed ID: 11797012
[TBL] [Abstract][Full Text] [Related]
19. Simian immunodeficiency virus (SIV) gag DNA-vaccinated rhesus monkeys develop secondary cytotoxic T-lymphocyte responses and control viral replication after pathogenic SIV infection.
Egan MA; Charini WA; Kuroda MJ; Schmitz JE; Racz P; Tenner-Racz K; Manson K; Wyand M; Lifton MA; Nickerson CE; Fu T; Shiver JW; Letvin NL
J Virol; 2000 Aug; 74(16):7485-95. PubMed ID: 10906202
[TBL] [Abstract][Full Text] [Related]
20. Reduction of simian-human immunodeficiency virus 89.6P viremia in rhesus monkeys by recombinant modified vaccinia virus Ankara vaccination.
Barouch DH; Santra S; Kuroda MJ; Schmitz JE; Plishka R; Buckler-White A; Gaitan AE; Zin R; Nam JH; Wyatt LS; Lifton MA; Nickerson CE; Moss B; Montefiori DC; Hirsch VM; Letvin NL
J Virol; 2001 Jun; 75(11):5151-8. PubMed ID: 11333896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
